EP3391026A1 - Method for detecting particles in a sample, detection device, and microfluidic system for examining a sample - Google Patents
Method for detecting particles in a sample, detection device, and microfluidic system for examining a sampleInfo
- Publication number
- EP3391026A1 EP3391026A1 EP16825719.4A EP16825719A EP3391026A1 EP 3391026 A1 EP3391026 A1 EP 3391026A1 EP 16825719 A EP16825719 A EP 16825719A EP 3391026 A1 EP3391026 A1 EP 3391026A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- magnetic field
- detection
- particles
- sample
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002245 particle Substances 0.000 title claims abstract description 188
- 238000001514 detection method Methods 0.000 title claims abstract description 174
- 238000000034 method Methods 0.000 title claims abstract description 54
- 230000005291 magnetic effect Effects 0.000 claims abstract description 162
- 238000005259 measurement Methods 0.000 claims abstract description 48
- 102000018697 Membrane Proteins Human genes 0.000 claims description 6
- 108010052285 Membrane Proteins Proteins 0.000 claims description 6
- 238000004590 computer program Methods 0.000 claims description 6
- 230000001419 dependent effect Effects 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 230000005298 paramagnetic effect Effects 0.000 claims description 5
- 230000008569 process Effects 0.000 abstract description 7
- 239000000523 sample Substances 0.000 description 71
- 210000004027 cell Anatomy 0.000 description 25
- 230000008901 benefit Effects 0.000 description 18
- 239000007788 liquid Substances 0.000 description 9
- 238000003018 immunoassay Methods 0.000 description 8
- 229920005597 polymer membrane Polymers 0.000 description 8
- 229920000307 polymer substrate Polymers 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 238000004891 communication Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000006249 magnetic particle Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000005653 Brownian motion process Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000005537 brownian motion Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 241000238366 Cephalopoda Species 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000005266 circulating tumour cell Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/72—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables
- G01N27/74—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids
- G01N27/745—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids for detecting magnetic beads used in biochemical assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/1031—Investigating individual particles by measuring electrical or magnetic effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/12—Measuring magnetic properties of articles or specimens of solids or fluids
- G01R33/1269—Measuring magnetic properties of articles or specimens of solids or fluids of molecules labeled with magnetic beads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
Definitions
- the invention is based on a device or a method according to the preamble of the independent claims.
- the subject of the present invention is also a computer program.
- particles to be detected in a sample can be detected in particular by magnetic detection of magnetic detection particles which can bind with the particles to be detected.
- a binding state of the detection particles can be detected, which can be related to a fluctuation of the detected magnetic field.
- a process time or duration for the examination of samples or for the detection of particles can be shortened.
- a qualitative and additionally or alternatively a quantitative detection of particles can be provided.
- at least one detection particle needs to be added to a sample so that material costs can also be reduced.
- Westentabelaborsysteme or lab-on-chip systems are simplified. According to embodiments of the present invention, it may also be possible to detect individual particles. Detection according to embodiments of the present invention may be conducted without contact and without optically transparent access to the sample. Furthermore, material selection among electrical dielectrics for such lab-on-chip systems can be increased.
- a method for the detection of particles in a sample is presented, the method having the following features:
- Reading in a measurement signal comprising at least one detected property of at least one subset of the sample
- Magnetic field represents, from an interface to at least one
- Magnetic field sensor wherein the sample of magnetic detection particles are added, which are adapted to bind to the particles to be detected;
- the sample may be a liquid sample or a sample in a liquid state.
- the sample can be arranged in a container and optionally stirred.
- the container may be formed as a vessel or a channel, wherein the sample can optionally be moved through the container.
- Fluctuation strength can be a fluctuation range of the measurement signal
- a magnetic particle is bound to a particle to be detected, in particular a biological particle such as a cell, without, for example, undergoing a complicated immunoassay workflow.
- a method of detecting particles in the form of cells may be used for microfluidic lab-on-chip medical diagnostic systems.
- Binding state can be determined as unbound, if the fluctuation strength is in a first range of values.
- the binding state in the step of determining, can be determined as bound to a particle to be detected, if the fluctuation intensity lies in a second value range which represents lower fluctuation strengths than the first value range.
- the fluctuation strength of an unbound detection particle may be greater than the fluctuation strength of a detection particle bound to a particle to be detected.
- Binding state can be reliably determined and thus an accurate and reliable detection of a presence or absence of detected particles is made possible. Also, in the step of reading a measurement signal can be read, the one
- Strength of the magnetic field and additionally or alternatively represents a direction of the magnetic field over time offers the advantage that an accuracy of a detection of the at least one
- the method may include a step of adding a predefined amount of the magnetic detection particles to the sample.
- the detection particles may be contained in a liquid, solution or the like.
- Such an embodiment offers the advantage that a concentration of the detection particles in the sample can be accurately adjusted. Also in this case, for example, the concentration of the detection particles in the sample can be adjusted so that in each case a detection particle is in the region of the magnetic field sensor in order to increase a measurement accuracy.
- detection particles can be added, which are adapted to antibody and additionally or alternatively to
- the particles to be detected can be biological particles.
- magnetic detection particles may be added to the sample.
- Detection particles have a magnetic portion and a binding portion, in particular an antibody portion or the like. Such an embodiment offers the advantage that, for example, cells or microorganisms can be detected specifically and reliably. In the case of paramagnetic detection particles, a
- Detection accuracy can be further improved, in addition in particular a calibration of the at least one magnetic field sensor and the
- Verification process allows or can be facilitated.
- the method may include a step of generating the magnetic field.
- the measurement signal read in in the step of reading in may represent at least one property of the generated magnetic field.
- Magnetic field are generated. Additionally or alternatively, in the step of generating a magnetic field can be generated, which is designed to at least Immobilize detection particles adjacent to the at least one magnetic field sensor.
- a rotation of the detection particles can be prevented by a homogeneous magnetic field and thus a detection accuracy can be increased, wherein by a magnetic holding the detection particles in a flowing sample a more accurate
- Detection can be performed on individual detection particles.
- the immobilization may cause a detection particle relative to a
- Magnetic field sensor can be positioned exactly.
- the method may include a step of circulating the sample with the added detection particles.
- the step of circulating before, during and additionally or alternatively after detecting the at least one property of the magnetic field can be executed.
- the sample can be circulated using a pump or a stirrer.
- the sample may be used between determining the
- Binding state of a first detection particle and determining the binding state of a second detection particle are circulated.
- the sample may be circulated continuously, with time intervals between determining the binding state different
- Detection particles can be shortened and low-frequency signal components can be filtered out of the measurement signal. Such an embodiment offers the advantage that the binding state of detection particles
- the device may comprise at least one computing unit for processing signals or data, at least one memory unit for storing signals or data, at least one interface to a sensor or an actuator for reading sensor signals from the sensor or for outputting data or control signals to the sensor Actuator and / or at least one
- the arithmetic unit may be, for example, a signal processor, a microcontroller or the like, wherein the memory unit is a flash memory, an EPROM or a
- the magnetic storage unit can be.
- the communication interface can be designed to read or output data wirelessly and / or by line, wherein a communication interface that can read or output line-bound data, for example, electrically or optically read this data from a corresponding data transmission line or output in a corresponding data transmission line.
- a device can be understood as meaning an electrical device which processes sensor signals and outputs control and / or data signals in dependence thereon.
- the device may have an interface, which may be formed in hardware and / or software.
- the interfaces can be part of a so-called system ASIC, for example, which contains a wide variety of functions of the device.
- the interfaces are their own integrated circuits or at least partially consist of discrete components.
- the interfaces may be software modules that are present, for example, on a microcontroller in addition to other software modules.
- Device a control of at least one magnetic field sensor and additionally or alternatively at least a portion of a microfluidic system.
- the device can, for example, sensor signals such as
- the device may be configured to respond to the measurement signal, to the determined fluctuation intensity and additionally or alternatively, to generate and provide or output at least one drive signal to the determined binding state.
- the activation takes place via actuators such as pumps, stirrers and additionally or alternatively devices for generating a magnetic field.
- a microfluidic system for assaying a sample comprising: an embodiment of the above-mentioned detection device; and an interface for coupling to the at least one magnetic field sensor, wherein the measurement signal is transferable via the interface to the detection device.
- the detection device according to one embodiment mentioned above can advantageously be used to detect the particles when the sample is examined.
- the interface can be designed to produce a releasable mechanical and additionally or alternatively signal-transmissible connection between the microfluidic system and the at least one magnetic field sensor.
- the microfluidic system may have a microfluidic channel in which the sample may be feasible.
- the detection device and additionally or alternatively the interface may be arranged adjacent to the microfluidic channel.
- the microfluidic system can be designed as a so-called west pocket laboratory (LoC, lab on chip, laboratory on a chip).
- LoC west pocket laboratory
- the interface may be designed to be the at least one
- the wall of the microfluidic channel may be elastic, wherein the interface may be formed to the Wall of the microfluidic channel to deform by the at least one magnetic field sensor.
- Detection accuracy can be further increased because a distance between the sample and the at least one magnetic field sensor can be minimized.
- the microfluidic system may comprise at least one magnetic field sensor which may be removably coupled or coupleable to the interface.
- the at least one magnetic field sensor may, for example, be a one-dimensional magnetic field sensor or a three-dimensional one
- Such an embodiment offers the advantage that an accurate detection of particles on the one hand can be achieved by simple and inexpensive means by a one-dimensional sensor and on the other hand a security in the detection of the binding state by using a three-dimensional sensor can be further increased.
- a computer program product or computer program with program code which can be stored on a machine-readable carrier or storage medium such as a semiconductor memory, a hard disk memory or an optical memory and for carrying out, implementing and / or controlling the steps of the method according to one of the above
- FIG. 1 shows a schematic representation of a microfluidic system according to an embodiment
- FIG. 2 is a flowchart of a method for detecting particles according to an embodiment
- Fig. 5 is a schematic sectional view of a part of a microfluidic system according to an embodiment.
- bioassays are used to detect substances such as proteins, DNA molecules (DNA, deoxyribonucleic acid) or cells, for example pathogens, body cells or circulating
- CTCs Circulating Tumor Cells
- B. Circulating Tumor Cells
- detection antibodies are used which bind to a specific surface protein of a cell.
- fluorescent probes or magnetic particles so-called
- Detection antibodies are used, which bind either to the detection antibody or to another surface protein of the cell. If the detection antibody immobilized on a surface, the detection antibodies and thus also the cells to be detected can be located and detected, it is a so-called sandwich immunoassay. Immunoassays are available in a variety of variations. For example, conventional immunoassays include a sequence of many substeps, e.g. B. adding sample,
- Immunoassays can be expensive to carry out.
- the end result is information as to whether or not the probes (eg, magnetic particles) have bound to the cells to be detected. Furthermore, can optionally determine how many probes have bound to cells to allow for concentration determination.
- FIG. 1 shows a schematic representation of a microfluidic system 100 for examining a sample 102 according to an exemplary embodiment.
- the sample 102 contains particles 104 to be detected. Further, the sample 102
- Detection particles are designed to bind to the particles 104 to be detected or to enter into a chemical, physical or physicochemical bond with the particles 104 to be detected.
- the microfluidic system 100 has an interface 110 and a
- the interface 110 is designed to enable a coupling with at least one magnetic field sensor 130.
- the interface 110 is coupled with at least one magnetic field sensor 130.
- the coupling between the interface 110 and the at least one magnetic field sensor 130 takes place here mechanically and / or signal transmission capability.
- a measurement signal 115 from a magnetic field sensor 130 coupled to the interface 110 can be transmitted to the detection device 120.
- a magnetic field sensor 130 is shown coupled to the interface 110.
- the magnetic field sensor 130 is detachably coupled to the interface 110.
- the magnetic field sensor 130 is configured to detect at least one property of a magnetic field that extends through at least a portion of the sample 102.
- the at least one property of the magnetic field is in this case in particular a strength and / or direction of the magnetic field over time.
- the magnetic field sensor 130 is configured to provide or output the measurement signal 115.
- the measuring signal 115 represents the at least one detected characteristic of the magnetic field.
- the detection device 120 is designed to detect the particles 104 to be detected or the particles 104 in the sample 102.
- the detection device 120 has a read-in device 121, a Detection device 122 and a determination device 123.
- the detection device 120 is designed to detect, in response to the measurement signal 115 and / or using the measurement signal 115, whether the particles 104 are present in the sample 102 or not.
- the read-in device 121 of the detection device 120 is designed to read in the measurement signal 115 from the interface 110 to the magnetic field sensor 130. Furthermore, the read-in device 121 is designed to output the read measurement signal 115 to the determination device 122 or to provide it to the determination device 122. The read-in device 121 is connected to the detection device 122 in a signal-transmitting manner.
- the determination device 122 is designed to use the measurement signal 115 to determine a fluctuation intensity of the at least one property of the magnetic field represented by the measurement signal 115.
- Fluctuation strength is dependent on the detection particles 106.
- the fluctuation intensity of the measurement signal 115 or the at least one property of the magnetic field represented by the measurement signal 115 is dependent on the presence of at least one detection particle 106 in the magnetic field.
- the determination device 123 is signal-transmitting with the
- the determination device 120 is designed to determine a binding state of at least one of the binding forces as a function of the fluctuation intensity determined by the determination device 122
- Detection particle 106 in the magnetic field as unbound or bound to a detected particle 104 to determine. Based on the
- determined binding state of the at least one detection particle 106, the particles 104 in the sample 102 can be detected qualitatively and / or quantitatively.
- the determination device 123 is designed to be the
- Fluctuation strength is in a first range of values. Furthermore, the
- Determining means 123 adapted to the binding state as on Particle 104 to be detected bound to determine if the determined fluctuation strength is in a second range of values.
- the second value range represents lower fluctuation strengths than the first value range.
- a lower fluctuation strength or a fluctuation strength in the second value range corresponds to a bound state of the
- Detection particle 106 wherein a higher fluctuation strength or a fluctuation strength in the first value range corresponds to an unbound state of the detection particle 106.
- the microfluidic system 100 has according to the one shown in FIG.
- Embodiment further comprises a microfluidic channel 140.
- the microfluidic channel 140 is shaped to receive the sample 102 at the
- the interface 110 with the coupled magnetic field sensor 130 is arranged adjacent to the sample 102 or to the microfluidic channel 140.
- the detection device 120 is arranged adjacent to the sample 102 or to the microfluidic channel 140.
- the interface 110 is configured to accommodate the
- Magnetic field sensor 130 in contact with a wall of the microfluidic channel 140 to arrange or move.
- the sample 102 contains biological material, wherein the particles 104 to be detected are biological particles, in particular cells, organic molecules or the like.
- the detection particles 106 are designed to bind to antibodies and / or surface proteins of the
- the detection particles 106 may additionally or alternatively be designed as paramagnetic detection particles 106.
- the microfluidic system 100 has a generating device 150 for generating the magnetic field.
- the generating device 150 is designed to generate a homogeneous magnetic field.
- the generating device 150 is designed to be a
- the microfluidic system 100 has an optional circulation device 160.
- Recirculation device 160 is configured to agitate or circulate sample 102, particularly within microfluidic channel 140.
- Recirculation device 160 is configured, for example, as a pump or stirrer.
- Detection device 120 signal transmitting capable connected to the generating device 150 and the circulating device 160.
- Detection device 120 signal transmitting capable connected to the generating device 150 and the circulating device 160.
- Detection device 120 formed to at least one drive signal 170 to the generating device 150 and / or the circulation device 160th
- FIG. 2 shows a flow diagram of a method 200 for the detection of
- the method 200 for detection can be carried out in conjunction with the detection device from FIG. 1 or a similar detection device. Also, the method 200 may be practiced for detection in conjunction with the microfluidic system of FIG. 1 or a similar microfluidic system.
- the method 200 for detection comprises a step 210 of reading in a measurement signal from an interface to at least one magnetic field sensor.
- the measurement signal represents at least one detected property of at least one subset of the sample extending therethrough Magnetic field.
- Added to the sample are magnetic detection particles which are designed to bind to the particles to be detected.
- step 220 of the determination which can subsequently be carried out with respect to the step 210 of the read-in, in the method 200 one of the
- a binding state becomes at least one depending on the fluctuation intensity determined in the step 220 of the determination
- Detection particles as unbound or bound to a detected particle determined.
- the particles in the sample can be qualitatively and / or quantitatively detected.
- the read-in step 210, the determination step 220, and the determination-determining step 230 are repeatably executable, for example, for a plurality of detection particles n in succession.
- the method 200 for detecting comprises a step 240 of adding a predefined amount of magnetic
- step 240 of the addition is executable before the step 210 of the read-in.
- detection particles which are designed to bind to antibodies and / or surface proteins of the particles to be detected if the particles to be detected are biological particles can be added in step 240 of the adding.
- paramagnetic particles which are designed to bind to antibodies and / or surface proteins of the particles to be detected if the particles to be detected are biological particles can be added in step 240 of the adding.
- paramagnetic particles which are designed to bind to antibodies and / or surface proteins of the particles to be detected if the particles to be detected are biological particles can be added in step 240 of the adding.
- paramagnetic particles which are designed to bind to antibodies and / or surface proteins of the particles to be detected if the particles to be detected are biological particles can be added in step 240 of the adding.
- paramagnetic particles which are designed to bind to antibodies and / or surface proteins of the particles to be detected if the particles to be detected are biological particles can be added in step 240 of
- Detection particles are added to the sample.
- the method 200 for detecting comprises a step 250 of generating, wherein the magnetic field is generated.
- the step 250 of generating is executable prior to the step 210 of the read-in.
- the step 250 of generating between the step 240 of the admit and the step 210 of the read in is executable.
- the measurement signal read in in step 210 of the read-in represents at least one property of that generated in step 250 of the generation Magnetic field.
- a homogeneous magnetic field is generated as the magnetic field.
- a magnetic field is generated that is configured to immobilize at least one detection particle adjacent to the at least one magnetic field sensor.
- the method 200 for detecting comprises a step 260 of circulating the sample with the added detection particles.
- the recirculation step 260 can be implemented, for example, by stirring or pumping the sample.
- the step 220 of determining and determining step 230 Circulating optionally prior to the step 210 of reading in parallel to the step 210 of reading in, the step 220 of determining and determining step 230, after the step 230 of determining and / or between the step 230 of determining and subsequently performing the
- Step 210 of reading in executable Step 210 of reading in executable.
- Fig. 3 shows a diagram of magnetic field strengths over time.
- the time is plotted on an abscissa axis of the diagram labeled x, in particular in arbitrary units, with an inscription labeled y
- the measurement signals are possible measurement signals which are generated in the detection device from FIG. 1 or a similar detection device or the microfluidic system from FIG. 1 or a similar microfluidic system.
- a first graph 304 represents a first measurement signal having a first fluctuation width.
- the first graph 304 represents a measurement signal for a particle bound to a detected particle
- the first graph 304 has a low
- a second graph 306 represents a second measurement signal having a second fluctuation amount.
- the second graph 306 represents a measurement signal for a freely moving detection particle without binding to a particle to be detected.
- the second graph 306 has a high fluctuation strength, that is, the changes of the signal within one
- Time steps are high and higher than in the first graph 304.
- the proportionality factor 2 f Do of equation (1) is generally referred to as fluctuation strength ⁇ ⁇ .
- a magnetic particle such as the detection particles of Fig. 1 and Fig. 2
- a liquid within a vessel on the wall of an example one-dimensional magnetic field sensor, for.
- Hall sensor As Hall sensor, AMR or GMR magnetometer, MEMS sensor or SQUID, is attached, the measured magnetic field strength will fluctuate over time. The reason for this is a changing distance between particle and magnetic field sensor and a change in the direction of the magnetic field due to a rotation of the particle.
- a fluctuation strength ⁇ can be determined analogously to equation (1).
- the fluctuation strength ⁇ is higher the smaller the particle is.
- the fluctuation amount ⁇ will decrease as the magnetic detection particle binds to a particle to be detected, for example, a cell to be detected or the like is because the magnetic detection particle and the particle to be detected move together through the sample or the liquid.
- Fig. 4 shows a schematic sectional view of a part of a
- Microfluidic system 100 according to one embodiment.
- the microfluidic system 100 here corresponds to the microfluidic system of FIG. 1 or a similar microfluidic system, wherein in the illustration of FIG. 4, only a partial section of the microfluidic system is shown in a more detailed manner compared to FIG.
- the microfluidic system 100 has, according to the exemplary embodiment illustrated in FIG. 4, a polymeric multilayer structure.
- the magnetic field sensor 130 the microfluidic channel 140
- Magnetic field sensor 130 a first polymer substrate 441 with the microfluidic channel 140, a second polymer substrate 442, a polymer membrane 444 and a recess 445 and a recess portion 445 in the second polymer substrate 442 shown.
- the interface for coupling with the magnetic field sensor 130 is in this case designed as a part of the holding device 410, which is not explicitly shown in FIG. 4.
- the fixture 410 may represent the interface.
- FIG. 4 shows a cross section through a
- Multilayer structure of the microfluidic system 100 consisting of two polymer substrates 441 and 442 separated by a flexible polymer membrane 444.
- the microfluidic channel 140 extends.
- the second polymer substrate 442 is the
- Polymer membrane 444 is exposed or exposed.
- the magnetic field sensor 130 is attached to the holding device 410.
- the holding device 410 is moved in the direction of the Multilayer structure pushed, in particular in the recess portion 445 in until the magnetic field sensor 130 has contact with the polymer membrane 444.
- Fig. 5 shows a schematic sectional view of a part of a
- Microfluidic system 100 corresponds to the microfluidic system from FIG. 4, or the illustration in FIG. 5 corresponds to the illustration from FIG. 4, with the exception that the microfluidic system attached to the holding device 410
- Magnetic field sensor 130 is arranged in Fig. 5 in contact with the polymer membrane 444 or moved.
- the magnetic field sensor 130 is pressed into the polymer membrane 444, so that the polymer membrane 444 is deformed. In this way, it can be achieved that the magnetic field sensor 130 has a full contact with the polymer membrane 444 and is thus close to a sample when it is passed through the microfluidic channel 140.
- a detection interval or measuring interval Et may be 1
- One measurement period per particle can be at
- Magnetic field sensor 130 for example 500 milliseconds to 30 seconds.
- a field strength of a homogeneous magnetic field can be, for example, 10 microtesla to 1000 millitesla, in particular 500 microtesla to 500 millitesla.
- a diameter of the magnetic detection particles 106 may be, for example, 100 nanometers to 100 micrometers, especially 500
- polymers for the polymer substrates 441 and 442 include polymers, especially thermoplastics, e.g. As PC, PP, PE, PMMA, COP, COC, wherein for the Polymeric membrane 444 can be used for example elastomers, thermoplastic elastomers, thermoplastics, hot-melt adhesive films or the like.
- a thickness of the polymer substrates 441 and 442 may be, for example, 0.1 mm to 10 mm, in particular 1 mm to 3 mm.
- a thickness of the polymer membrane 444 may be, for example, 5 microns to 500 microns, especially 50 microns to 150 microns.
- magnetic detection particles 106 are used, which in the case of
- Immunoassays by an immune reaction specifically bind to detectable cells or particles 104.
- the magnetic field sensor 130 is used to determine the strength and / or direction of the magnetic field over time of at least one detection particle 106 in at least one spatial dimension. From the recorded measurement signal 115, the fluctuation intensity is determined in the next step 220.
- the intensity of fluctuation for a detection particle 106 without binding to a cell or a particle 104 differs from that of a detection particle 106 bound to a cell or a particle 104.
- the microfluidic system 100 is embodied as a polymeric multilayer structure which has an interface 110 to, for example, a magnetic field sensor 130.
- the magnetic field sensor 130 can be arranged in or adjacent to a drive unit for the lab-on-chip system or microfluidic system 100.
- the method for detecting comprises the following steps:
- Add 240 of magnetic detection particles 106 for example, suspended in a liquid, wherein the detection particles 106 bind to the cells or particles 104 to be detected, for example, with
- the concentration of the magnetic detection particles 106 is selected, for example, in step 240 of the addition so that in each case only a single detection particle 106 is arranged within a range of the magnetic field sensor 130.
- the step 260 of the circulation is carried out so that a circulation of the sample 102 takes place and another detection particle 106 can be measured.
- the circulation can take place for example via a stirrer or by external / internal pumps.
- Magnetic field sensor 130 used. This makes it possible to at least partially separate a rotational component of the fluctuation intensity from a translation component.
- Such an embodiment has the particular advantage that the binding state can be determined by means of two separate variables, ie rotational component and translation component, and thus an even higher level of certainty in the detection of the binding state can be achieved.
- the sample 102 is within the
- Range of the magnetic field sensor 130 at least during the measuring process of a homogeneous magnetic field interspersed, generated in step 250 of the generating z. B. via a Helmholtz coil arrangement. In this way, the magnetic moments of the detection particles 106 align within the homogeneous magnetic field and a rotational movement is prevented.
- paramagnetic detection particles 106 are used in step 240 of adding. As a result, the magnetic moment of the detection particles 106 is formed in combination with the homogeneous magnetic field. This embodiment has
- Magnetic field sensor 130 is. If this function is known, for example, by means of appropriate simulations, the measurement signal H (t) 115 can be used to directly generate a
- Trajectory d (t) of the detection particles 106 derived.
- the diffusion coefficient Do and thus the radius of the detection particle 106 can be calculated from the trajectory d (t).
- This has the advantage that a known quantity, the radius of the free or unbound detection particle 106, is obtained as the measured value and thus, for example, an exact and reliable calibration can be carried out.
- it is favorable to additionally consider that the diffusion coefficient Do in the vicinity of a wall is not constant, but depends on the distance to the wall.
- the magnetic field sensor 130 is in
- microfluidic channel 140 pumped, for example by external or microfluidic integrated pumps.
- Magnetic field sensor 130 generates a measurement signal 115, the flow is stopped and the binding state of the detection particle 106 is evaluated. Subsequently, the process for the next detection particle 106 is repeated.
- This has the particular advantage that the binding state of each detection particle 106 can be determined exactly once.
- the detection particle 106 can be positioned accurately over the magnetic field sensor 130, so that a high measurement signal 115 can be generated. In addition, this allows to determine the number of detection particles 106, each to a
- the magnetic field may be generated in step 250 of the generating so that a potential well is formed in the vicinity of the magnetic field sensor 130 for the detection particle 106, i. H. in the sense of a so-called Magnetic Tweezers. That way that can
- Detection particles 106 are more closely held in the vicinity of the magnetic field sensor 130.
- the sample 102 is continuously pumped through the microfluidic channel 140 in step 260 of the circulation and the
- Magnetic field sensor 130 performed. It is advantageous to discard low-frequency components on the measurement signal 115 before the evaluation of the measurement signal 115, which are due to the variable distance to the magnetic field sensor 130 during the
- the liquid or sample 102 conducted past the magnetic field sensor 130 can be guided past the magnetic field sensor 130 at least a second time. This can be the
- the concentration of the cells or particles 104 to be detected can thus also be determined via the known concentration of the detection particles 106.
- the aforementioned multi-step immunoassay workflow may be shortened according to embodiments. For example, it eliminates all washing steps and the sample 102 only needs to be added a substance, a buffer with functionalized magnetic detection particles 106. This process times and material costs can be reduced. In addition, the shortened workflow can be more easily integrated into lab-on-chip systems or microfluidic systems 100.
- probes such as, for example, magnetic detection particles 106 or fluorescence-labeled molecules
- the detection method 200 allows the bonding state of a single magnetic detection particle 106 to be increased determine. This makes it possible to detect a single cell or a single particle 104.
- the method 200 for detecting also through the skin of a patient for magnetic detection particles 106 in a blood vessel. This allows a patient to use magnetic beads
- Detection particles 106 are injected, the binding state can be monitored continuously, for example via a magnetic field sensor 130 on the wrist, z. B. integrated into a smartwatch or the like. This can be used, for example, for the early detection of cancer, pathogens, viruses or for the follow-up of therapies.
- the interface 110 enables a magnetic field sensor 130, for example located in the drive system for the lab-on-chip system 100, in close proximity to the sample 102 to position. Since the magnetic field sensor 130 can be used multiple times or in several microfluidic systems 100, costs for a lab-on-chip system or microfluidic system 100 can be reduced.
- an exemplary embodiment comprises a "and / or" link between a first feature and a second feature, then this is to be read so that the embodiment according to one embodiment, both the first feature and the second feature and according to another embodiment either only first feature or only the second feature.
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102015225849.1A DE102015225849A1 (en) | 2015-12-18 | 2015-12-18 | Method for detecting particles in a sample, detection device and microfluidic system for assaying a sample |
PCT/EP2016/081470 WO2017103137A1 (en) | 2015-12-18 | 2016-12-16 | Method for detecting particles in a sample, detection device, and microfluidic system for examining a sample |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3391026A1 true EP3391026A1 (en) | 2018-10-24 |
Family
ID=57794231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16825719.4A Withdrawn EP3391026A1 (en) | 2015-12-18 | 2016-12-16 | Method for detecting particles in a sample, detection device, and microfluidic system for examining a sample |
Country Status (4)
Country | Link |
---|---|
US (1) | US20180372732A1 (en) |
EP (1) | EP3391026A1 (en) |
DE (1) | DE102015225849A1 (en) |
WO (1) | WO2017103137A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102018116918A1 (en) * | 2018-07-12 | 2020-01-16 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Fluidic detection system |
SE545151C2 (en) * | 2020-10-26 | 2023-04-18 | Compular Ab | Method and device for determining bonds in particle trajectories |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19503664C2 (en) * | 1995-01-27 | 1998-04-02 | Schering Ag | Magnetorelaxometric detection of analytes |
JP4676361B2 (en) * | 2006-03-09 | 2011-04-27 | 株式会社日立製作所 | Magnetic immunoassay device |
US9068977B2 (en) * | 2007-03-09 | 2015-06-30 | The Regents Of The University Of Michigan | Non-linear rotation rates of remotely driven particles and uses thereof |
US20080241964A1 (en) * | 2007-03-27 | 2008-10-02 | Canon Kabushiki Kaisha | Material for improving sensitivity of magnetic sensor and method thereof |
US20100188076A1 (en) * | 2007-07-09 | 2010-07-29 | Koninklijke Philips Electronics N.V. | Microelectronic sensor device with magnetic field generator and carrier |
DE102007057667A1 (en) * | 2007-11-30 | 2009-09-03 | Siemens Ag | Device for detecting particles in a fluid |
CN102576020B (en) * | 2009-09-28 | 2014-09-17 | 皇家飞利浦电子股份有限公司 | Method for characterization of biological bonds |
WO2012027747A2 (en) * | 2010-08-27 | 2012-03-01 | The Regents Of The University Of Michigan | Asynchronous magnetic bead rotation sensing systems and methods |
DE102010043276A1 (en) * | 2010-11-03 | 2012-05-03 | Siemens Aktiengesellschaft | Magnetic cell detection |
DE102013200927A1 (en) * | 2013-01-22 | 2014-07-24 | Siemens Aktiengesellschaft | Method for enriching and separating cells with concentrations over several logarithmic stages |
JP6258076B2 (en) * | 2014-02-28 | 2018-01-10 | 株式会社日立製作所 | Magnetic signal measuring apparatus and magnetic signal measuring method |
-
2015
- 2015-12-18 DE DE102015225849.1A patent/DE102015225849A1/en not_active Withdrawn
-
2016
- 2016-12-16 EP EP16825719.4A patent/EP3391026A1/en not_active Withdrawn
- 2016-12-16 WO PCT/EP2016/081470 patent/WO2017103137A1/en unknown
- 2016-12-16 US US16/062,110 patent/US20180372732A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE102015225849A1 (en) | 2017-06-22 |
WO2017103137A1 (en) | 2017-06-22 |
US20180372732A1 (en) | 2018-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2062643B1 (en) | Analysis system and method for analysing a bodily fluid sample on an analyte contained therein | |
DE19709348C2 (en) | Automatic multi-epitope ligand mapping process | |
DE112011102234B4 (en) | Detection of magnetic nanoparticles through a membrane | |
EP2654955B1 (en) | Method for mixing at least one sample solution with reagents | |
WO1999027367A1 (en) | Device and method for detecting analytes | |
DE102014200483B4 (en) | Method for operating a microfluidic chip and microfluidic chip | |
DE102016222510A1 (en) | Device for detecting target biomolecules | |
DE3784479T2 (en) | DIAGNOSTIC TOOL, ITS PRODUCTION AND USE. | |
WO2017103137A1 (en) | Method for detecting particles in a sample, detection device, and microfluidic system for examining a sample | |
EP3646029B1 (en) | Detection system and process for its production | |
DE102011055070B3 (en) | A sample analysis apparatus for determining samples in a sample matrix and methods for determining samples in one or more sample matrices | |
DE102015225847A1 (en) | Detection device and method for detecting at least one particle bound to at least one binding particle in a liquid | |
DE102008013997B4 (en) | Method for the quantitative detection of analytes in liquid medium | |
DE112019003898T5 (en) | ANALYSIS PROCEDURE, REAGENT KIT, AND ANALYSIS DEVICE | |
EP2092334B1 (en) | Analysis method, and portable analysis device | |
DE10130727C2 (en) | Method and device for measuring micro-viscosity changes as an immunoassay | |
EP2841940A1 (en) | Method and arrangement for detecting cells in a cell suspension | |
WO2000011432A1 (en) | Device and method for determining distances and a nano-dosing system belonging thereto | |
WO2002029430A1 (en) | Method and device for examining biological and/or chemical samples by means of giant magneto-impedance (gmi) | |
DE102010043276A1 (en) | Magnetic cell detection | |
EP0486978B1 (en) | Method and device for quantitative evaluation of agglutination reactions | |
DE10050029B4 (en) | Chemical sensor with magnetic particles | |
WO2013186049A1 (en) | Method and arrangement for marking cells in a suspension of cells | |
DE102010014657A1 (en) | Method and apparatus for studying molecular bonds | |
DE102015122615A1 (en) | Apparatus and method for the quantitative determination of a substance concentration in a liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180718 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ROBERT BOSCH GMBH |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210622 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20211130 |